QLY Biotech Group Corp.
QLY Biotech Group Corp. engages in the tourism business in the Dominican Republic. It organizes individual and group sailing tours. The company was formerly known as Azar International Corp. and changed its name to QLY Biotech Group Corp. in August 2022. QLY Biotech Group Corp. was incorporated in 2018 and is based in Las Vegas, Nevada.
QLY Biotech Group Corp. (LQLY) - Net Assets
Latest net assets as of February 2023: $-19.67K USD
Based on the latest financial reports, QLY Biotech Group Corp. (LQLY) has net assets worth $-19.67K USD as of February 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($0.00) and total liabilities ($19.67K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-19.67K |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 594.76 |
QLY Biotech Group Corp. - Net Assets Trend (2019–2022)
This chart illustrates how QLY Biotech Group Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for QLY Biotech Group Corp. (2019–2022)
The table below shows the annual net assets of QLY Biotech Group Corp. from 2019 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-08-31 | $0.00 | -- |
| 2021-08-31 | $-5.96K | -125.33% |
| 2020-08-31 | $23.54K | +1064.19% |
| 2019-08-31 | $2.02K | -- |
Equity Component Analysis
This analysis shows how different components contribute to QLY Biotech Group Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4894700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.90K | % |
| Other Components | $46.03K | % |
| Total Equity | $0.00 | 100.00% |
QLY Biotech Group Corp. Competitors by Market Cap
The table below lists competitors of QLY Biotech Group Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GP Global Power Ltd
TA:GPGB
|
$895.38K |
|
Central Petroleum Limited
PINK:CNPTF
|
$895.58K |
|
Golf & Co Group Ltd
TA:GOLF
|
$895.79K |
|
Atco Mining Inc.
PINK:ATMGF
|
$895.93K |
|
MGT Capital Investments Inc
PINK:MGTI
|
$894.82K |
|
MAYR-MELNHOF KARTON - Dusseldorf Stock Exchang
DU:MYM
|
$894.66K |
|
Freedom Holdings Inc
PINK:FHLD
|
$894.13K |
|
WEBUY GLOBAL LTD. Ordinary Shares
NASDAQ:WBUY
|
$893.97K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in QLY Biotech Group Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -5,963 to 0, a change of 5,963.
- Net loss of 14,112 reduced equity.
- Other factors increased equity by 20,075.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-14.11K | -0.0% |
| Other Changes | $20.07K | +0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares QLY Biotech Group Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-08-31 | $0.00 | $1.00 | x |
| 2020-08-31 | $0.01 | $1.00 | x |
| 2021-08-31 | $0.00 | $1.00 | x |
| 2022-08-31 | $0.00 | $1.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently QLY Biotech Group Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-17.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -48.37% | 0.00% | 0.00x | 2.47x | $-1.18K |
| 2020 | -22.65% | -133.30% | 0.13x | 1.33x | $-7.69K |
| 2021 | 0.00% | -737.58% | 0.56x | 0.00x | $-28.91K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.11K |
Industry Comparison
This section compares QLY Biotech Group Corp.'s net assets metrics with peer companies in the Travel Services industry.
Industry Context
- Industry: Travel Services
- Average net assets among peers: $1,526,974,464
- Average return on equity (ROE) among peers: -30.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| QLY Biotech Group Corp. (LQLY) | $-19.67K | -48.37% | N/A | $894.99K |
| Airbnb Inc (ABNB) | $-517.31 Million | 0.00% | 0.00x | $53.81 Billion |
| Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares (AHMA) | $4.00 Million | 32.27% | 1.02x | $9.98 Million |
| Booking Holdings Inc (BKNG) | $402.60 Million | -262.07% | 0.10x | $140.30 Billion |
| Carnival Corporation (CCL) | $13.79 Billion | 8.61% | 0.78x | $32.20 Billion |
| Consolidated Capital of North America Inc (CDNO) | $93.27K | 0.00% | 0.02x | $8.78 |
| Carnival Plc ADS (CUK) | $207.80 Million | 47.02% | 1.54x | $32.14 Billion |
| Carnival Corporation & plc (CUKPF) | $893.20 Million | 21.67% | 1.49x | $18.29 Billion |
| Despegar.com Corp (DESP) | $92.85 Million | -151.47% | 8.10x | $1.36 Billion |
| Jet2 plc (DRTGF) | $157.20 Million | 20.87% | 5.37x | $2.31 Billion |
| eDreams ODIGEO S.A (EDDRF) | $236.30 Million | -18.34% | 3.54x | $429.02 Million |